BCAR4 and breast cancer: In 2006, it was first discovered that lncRNAs, specifically the ectopic expression of BCAR4 (breast cancer antiestrogen resistance 4), can significantly affect the degree of tamoxifen resistance in ZR-75-1 human breast cancer cells [15].